Skip to main content
. 2014 Mar;80(5):1692–1700. doi: 10.1128/AEM.03411-13

TABLE 1.

Unique genes from Venn diagram analysis of HT-29 cells challenged with poly(I·C) only and PC only in descending order of fold change in expressiona

Challenge (no. of unique genes), immune gene protein Function Immune pathway(s) Fold change in expressionb
Poly(I·C) only (n = 37)
    IL-17C (cytokine) T cell-derived cytokine that stimulates the release of TNF-α and IL-1β Inflammatory cytokine and receptors 12.41
    LTB (cytokine) Cytokine with a specific role in immune response regulation Cytokine-cytokine receptor interaction 8.20
    TNF-α (cytokine) Potent proinflammatory cytokine, involved in inflammatory responses MAPK signaling pathway, TGF-β signaling pathway, cytokine-cytokine receptor interaction 6.77
    CSF2 (cytokine) Cytokine that stimulates growth and differentiation JAK-STAT signaling, cytokine-cytokine receptor interaction, T cell receptor signaling 6.31
    NF-κB2 Pleiotropic transcription factor involved in inflammation, immunity, differentiation, cell growth, tumorigenesis, and apoptosis MAPK signaling pathway, NF-κB signaling pathway 5.32
    CDKN1A Intermediate inhibitor of cellular proliferation in response to DNA damage p53 signaling, cell cycle 4.72
    CSF1 (cytokine) Granulocyte-macrophage colony-stimulating factors that have a role in immune defenses Cytokine-cytokine receptor interaction 4.14
    IRF1 Transcriptional activator for IFN-α-, IFN-β-, and IFN-γ-stimulated genes, a modulator of virus-induced signaling NF-κB signaling pathway, TLR signaling pathway 3.86
    BMP2 Member of the TGF-β superfamily TGF-β signaling pathway, cytokine-cytokine receptor interaction 3.77
    RELB Component of the NF-κB RelB-p52 complex MAPK signaling pathway, NF-κB signaling pathway 3.38
    BF Not in Gene Cards database No pathway 3.17
    IL-32 (cytokine) Inducer of TNF-α and IL-8, activating cytokine signaling pathways of NF-κB and p38 MAPK Inflammatory response and autoimmunity 3.04
    OASL Binder to double-stranded RNA and DNA No KEGG pathway 2.95
    IFNGR2 Accessory factor of the IFN-γ signal transduction pathway Cytokine-cytokine receptor interaction 2.93
    TNFRSF12A Inducer of apoptosis in some cell types Cytokine-cytokine receptor interaction, NF-κB signaling pathway, apoptosis 2.89
    ICAM1 Adhesion molecule, intercellular 1, upregulated by cytokines CAMs 2.80
    ELF3 Transcriptional activator that binds and transactivates external transcribed spacer (ETS) sequences Selected targets of ESR1 2.74
    ISG20 Exonuclease involved in the antiviral function of IFN against RNA viruses IFN-α and IFN-β response 2.59
    IL-28B (cytokine) Protein with immunomodulatory activity that displays potent antiviral activity Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 2.52
    MAP2K3 Mitogen-activated protein kinase 3, critical component of TNF signaling MAPK signaling pathway, TLR signaling pathway 2.48
    NR4A1 Regulator of expression of delayed-early genes during liver regeneration MAPK signaling pathway 2.43
    VEGF Signaling protein involved in angiogenesis Cytokine-cytokine receptor interaction 2.39
    IFIT2 IFN-α-inducible protein induced by viral infections Interferons and receptors 2.38
    JUNB Transcription factor involved in regulating primary growth factor response MAPK signaling pathway, JAK-STAT signaling pathway 2.36
    BCL2L1 Potent inhibitor of cell death, regulating cell death by blocking the voltage-dependent anion channel (VDAC) Apoptosis, JAK-STAT signaling pathway 2.36
    IL-29 (cytokine) Protein involved in antiviral immunity and induced by viral infections or dsRNA Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 2.35
    STAT5A Protein involved in signal transduction and activation of transcription in response to cytokines JAK-STAT signaling pathway 2.35
    TRIF Adaptor used by TLR3 and TL4R to mediate NF-κB and interferon-regulatory factor (IRF) activation NF-κB signaling, TLR signaling pathway 2.26
    MAP3K11 Kinase that activates MAPK8/JNK kinase and functions as a positive regulator of the Jun N-terminal protein kinase signaling pathway MAPK signaling pathway 2.25
    NFKB1 Rapidly acting primary transcription factor that plays a key role in regulating the immune response to infection MAPK signaling pathway, NF-κB signaling pathway 2.20
    CLCF1 (cytokine) Cytokine with a B cell-stimulating capability Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 2.20
    GBP1 Guanylate binding protein mediating an antiviral response JAK-STAT signaling pathway 2.20
    DUSP5 Phosphatase that inactivates members of the MAPK superfamily MAPK signaling pathway 2.15
    IKBKE Noncanonical IκB kinase (IKK) that is essential for regulating antiviral signaling pathways NF-κB signaling pathway, TLR signaling pathway 2.14
    RGS3 Downregulator of G-protein-mediated release of inositol phosphates and activation of MAPKs G-protein signaling, G-protein alpha-q signaling cascades 2.05
    CXCL11 (chemokine) Chemotactic protein for interleukin-activated T cells Cytokine-cytokine receptor interaction, chemokine signaling pathway, TLR signaling pathway 2.04
    GCH1 Member of the GTP cyclohydrolase family in BH4 biosynthesis Nitric oxide signaling pathway, neurotransmitter receptors/regulators, IFN-α and IFN-β response 2.03
PC only (n = 3)
    IFITM1 IFN-induced antiviral protein that mediates cellular innate immunity Interferon signaling pathway, B cell receptor signaling pathway 2.36
    FGF19 Protein involved in the suppression of bile acid biosynthesis MAPK signaling pathway 2.20
    IFI44L Member of the IFI44 family Interferons and receptors pathway 2.10
a

Immune gene function data are from GeneCards (http://www.genecards.org), and immune pathway data are from KEGG (http://www.genome.jp/kegg/pathway.html).

b

All genes were upregulated. Fold change or expression ratio = 2log2ratio. A 2-fold change in differentially expressed genes and a P value of <0.05 were considered statistically significant.